Navigation Links
Digestive Enzyme Supplements Market to Reach $1.6 Billion by 2025 - Growing Consumer Awareness Regarding the Severity of Digestive Disorders - Research and Markets
Date:2/28/2017

DUBLIN, Feb 28, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Digestive Enzyme Supplements Market Forecasts 2014-2025" report to their offering.

The global digestive enzyme supplements market is expected to reach USD 1.6 billion by 2025. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected to stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, such as irritable bowel syndrome, constipation, inflammatory bowel disease, and gastroesophageal reflux disease, has raised concerns towards stomach health, which in turn is anticipated to fuel product growth.

Digestive enzyme supplements have to comply with various regulatory bodies including the U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994, and Natural Health Products Regulations for manufacturing and use. Increasing number of gymnasiums and fitness centers in emerging markets including China and India on account of rising awareness towards muscle improvement and reducing fat content among individuals will propel product demand.

Plant-based enzymes accounted for 41.3% of the overall revenue in 2015 and are expected to foresee considerable growth as these products aid in reducing acid indigestion, heartburn, reflux, and other digestive disturbances. Furthermore, the usability of these products across a wide range of pH levels is likely to expand their application.

Europe is expected to observe substantial revenue rise at a CAGR of 7.3% from 2016 to 2025. Easy availability of the product owing to the presence of a large number of supermarket chains along with increasing awareness regarding gastrointestinal problems is expected to fuel market size over the next nine years.

Central and South America is expected to foresee substantial growth owing to increasing prevalence of digestive disorders in the region. Increasing consumer awareness regarding the harm caused by the digestive system due to the lack of supplements and nutrients in the human body is anticipated to fuel expansion.

Companies Mentioned:

  • Klaire Laboratories
  • Enzymes, Inc.
  • ProteoZymes
  • National Enzyme Company
  • Enzymedica
  • AST Enzymes
  • VEMO 9OOD
  • Advanced Vital Enzymes Pvt. Ltd.
  • Zeus Biotech Limited
  • Vox Nutrition Inc.
  • Enzyme Bioscience Pvt. Ltd.
  • Metagenics
  • XYMOGEN Inc.
  • Douglas Laboratories
  • Thorne Research
  • Integrative Therapeutics, LLC
  • Pure Encapsulations
  • Ortho Molecular Products Inc.
  • Designs for Health Inc.
  • Master Supplements Inc.

Key Topics Covered:

1. Methodology and Scope

2. Executive Summary

3. Digestive Enzyme Supplements Market Variables, Trends & Scope

4. Digestive Enzyme Supplements Market: Origin Estimates & Trend Analysis

5. Digestive Enzyme Supplements Market: Application Estimates & Trend Analysis

6. Digestive Enzyme Supplements Market: Regional Estimates & Trend Analysis

7. Competitive Landscape

8. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/tx6dh4/digestive_enzyme

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/digestive-enzyme-supplements-market-to-reach-16-billion-by-2025---growing-consumer-awareness-regarding-the-severity-of-digestive-disorders---research-and-markets-300414622.html


'/>"/>
SOURCE Research and Markets
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Stretta Procedure for GERD: Successful 10 Year Follow-Up Data Presented at Digestive Disease Week--Sustained Improvement, Long-Term Efficacy
2. Inovio Pharmaceuticals Expands HPV Immunotherapy Development to Aerodigestive Cancers
3. UCB Announces Crohns Disease Data to be Presented at Digestive Disease Week 2015
4. Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients at Digestive Disease Week 2015
5. Alla Settimana delle malattie digestive, la terapia Stretta è stata presentata come un trattamento versatile ed efficace per svariate popolazioni di pazienti affetti dalla patologia MERG
6. Digestive Enzyme Supplements Market Size Worth $1.6 Billion By 2025: Grand View Research, Inc.
7. For Multiple Sclerosis Treatment, Prescriber Base for Genzymes Aubagio Among U.S. Neurologists Has Increased Significantly at Six Months Post-launch, Compared to One and Three Months Post-launch
8. Research by ClinMet Scientific Founder and Colleagues Point to Enzyme that Restores Function in Diabetic Kidney Disease
9. CA BOTANA Introduces SEA ENZYME CALIFORNIA BOTANICAL HAIR SERUM
10. Two-Thirds of Surveyed U.S. Neurologists Have Prescribed Genzymes Aubagio to Their Multiple Sclerosis Patients at One Year Post-Launch
11. Protein Structural Defects Are Enablers and Stimulators of Enzyme Catalysis, Scientist Ariel Fernandez Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... YORK , April 19, 2017 Global ... drainage devices are tubes used to remove excess liquid ... blood, serum, pus, urine, bile or lymph. Surgical drains ... of surgery such as orthopedics surgery, cardiovascular surgery, neurosurgery, ... is prophylactic post-surgery to prevent accumulation of fluid e.g. ...
(Date:4/19/2017)... , April 19, 2017 The ... Application, Forecast to 2022 report has covered and analysed the ... and information on market size, shares and growth factors. The ... drivers, challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 ...
(Date:4/19/2017)... 2017  New research provides evidence that an old drug ... a study released today that will be presented at the ... Boston , April 22 to 28, 2017. ... Parkinson,s disease, the oral drug levodopa has long been considered ... as the disease progresses, the effects of the medication can ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of the Year, ... providing information destruction , recycling, and compliance services to businesses throughout ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
(Date:4/21/2017)... Wis. (PRWEB) , ... April 21, 2017 , ... ... today announced that its B-595 and B-7569 vinyl label materials ... identification and warning labels are tested to remain intact and legible, for use on ...
(Date:4/21/2017)... Maine (PRWEB) , ... April 21, 2017 , ... ... today announced it’s been named Agency of Record (AOR) for Theravent, Inc. ... or eliminate snoring. Theravent’s parent company, Foundation Consumer Healthcare, is now working to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... an exciting new partnership with the highly regarded and well renowned Asian distributor, ... innovative, myTAP & myTAP PAP Nasal Pillow Mask, and will stabilize and strengthen ...
Breaking Medicine News(10 mins):